icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
Oct 11-15 2023
Boston, MA

Back grey_arrow_rt.gif
 
 
 
Randomized-controlled trial evaluating the outcome between switching to tenofovir disoproxil fumarate(TDF)/lamivudine(3TC)/dolutegravir(DTG) versus maintaining the current NNRTI or boosted-PI-containing regimen in PLWH in Thailand - a pilot study from single center
 
 
  ID Week 2023 Oct 13

1016231

1016232

1016233

1016234